Citius Oncology, Inc. Common Stock
CTORCitius Oncology, Inc. (CTOR) is a biopharmaceutical company focused on developing targeted cancer therapies. The company aims to advance innovative treatments by leveraging immunology and oncology research to improve outcomes for cancer patients.
$1.07 -0.05 (-4.46%)
Company News
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
Citius Oncology closed a $9.0 million registered direct offering and private placement, issuing 5,142,858 shares of common stock and accompanying warrants at $1.75 per share, with warrants exercisable at $1.84 per share.
